Browsing by Author "Saladié, Francina"

Sort by: Order: Results:

  • Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study
    Posso, Margarita; Corominas Torres, Josep Maria; Serrano, Laia; Román, Marta; Torá Rocamora, Isabel, 1979-; Domingo, Laia; Romero, Anabel; Quintana, María Jesús; Vernet-Tomás, Maria; Baré, Marisa; Vidal, Carmen; Sánchez, Mar; Saladié, Francina; Natal, Carmen; Ferrer, Joana; Servitja Tormo, Sonia; Sala, Maria; Castells, Xavier; BELE Study Group (Wiley, 2017)
    Women with benign breast diseases (BBD) have a high risk of breast cancer. However, no biomarkers have been clearly established to predict cancer in these women. Our aim was to explore whether estrogen receptor (ER), ...
  • Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain
    Román, Marta; Caicoya, Martin; Espinàs, Josep Alfons; Sala Serra, Maria; Torá Rocamora, Isabel, 1979-; Quinta, Maria J.; Vernet-Tomás, Maria; Saladié, Francina; Romero, Anabel; Sánchez, Mar; Baré, Marisa; Vidal, Carmen; Servitja Tormo, Sonia; Natal, Carmen; Corominas Torres, Josep Maria; Ferrer, Joana; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Wiley-Blackwell, 2018)
    Women with a benign breast disease (BBD) have an increased risk of subsequent breast carcinoma. Information is scarce regarding the characteristics of breast carcinomas diagnosed after a BBD. Our aim was to point out the ...
  • Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening
    Louro, Javier; Román, Marta; Posso, Margarita; Vázquez‐de las Heras, Ivonne; Saladié, Francina; Rodríguez Arana, Ana Maria; Quintana, María Jesús; Domingo Torrell, Laia; Baré, Marisa; Marcos-Gragera, Rafael; Vernet-Tomás, Maria; Sala, Maria; Castells, Xavier; BELE Study Group; IRIS Study Group; IRIS Study Group (Public Library of Science (PLoS), 2021)
    Background: Several studies have proposed personalized strategies based on women's individual breast cancer risk to improve the effectiveness of breast cancer screening. We designed and internally validated an individualized ...
  • Differences in breast cancer risk after benign breast disease by type of screening diagnosis
    Louro, Javier; Román, Marta; Posso, Margarita; Comerma Blesa, Laura, 1983-; Vidal, Carmen; Saladié, Francina; Alcántara da Silva, Rodrigo; Sánchez, Mar; Quintana, María Jesús; Del Riego, Javier; Ferrer, Joana; Peñalva, Lupe; Bargalló Castelló, Xavier; Prieto, Miguel; Sala Serra, Maria; Castells, Xavier (Elsevier, 2020)
    Introduction: We aimed to assess differences in breast cancer risk across benign breast disease diagnosed at prevalent or incident screens. Materials and methods: We conducted a retrospective cohort study with data from ...
  • Long-term risk of breast cancer after diagnosis of benign breast disease by screening mammography
    Román, Marta; Louro, Javier; Posso, Margarita; Vidal, Carmen; Bargalló Castelló, Xavier; Vázquez, Ivonne; Quintana, María Jesús; Alcántara da Silva, Rodrigo; Saladié, Francina; Riego, Javier del; Peñalva, Lupe; Sala, Maria; Castells, Xavier; BELE and IRIS Study Groups (MDPI, 2022)
    Assessing the long-term risk of breast cancer after diagnosis of benign breast disease by mammography is of utmost importance to design personalised screening strategies. We analysed individual-level data from 778,306 women ...
  • Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall
    Vernet-Tomás, Maria; Louro, Javier; Román, Marta; Saladié, Francina; Posso, Margarita; Prieto, Miguel; Vázquez, Ivonne; Baré, Marisa; Peñalva, Lupe; Vidal, Carmen; Bargalló Castelló, Xavier; Sánchez, Mar; Ferrer, Joana; Espinàs, Josep Alfons; Quintana, María Jesús; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Elsevier, 2021)
    Objective: We aimed to explore whether the type of mammographic feature prompting a false-positive recall (FPR) during mammography screening influences the risk and timing of breast cancer diagnosis, particularly if assessed ...